Dr Trevor Askwith (Head of Assay Biology) will be presenting at this event on the 19th May 2021. His talk will be part of the Fragment-Based Drug Discovery track and will be entitled "Accelerating Hit Expansion Using Creoptix waveRAPID® Technology". He will discuss the benefits of using Grating Coupled Interferometry and its  application to FBDD.